Literature DB >> 10933701

Existence of distinct GB virus C/hepatitis G virus variants with different tropism.

M Fogeda1, J M López-Alcorocho, J Bartolomé, C Arocena, M A Martín, V Carreño.   

Abstract

To study the existence of GB virus C/hepatitis G virus (GBV-C/HGV) variants with different tropism, we have analyzed the heterogeneity and quasispecies composition of GBV-C/HGV isolated from in vitro-infected peripheral blood mononuclear cells (PBMC) and from sera, livers, and PBMC from two chronically infected patients. For this purpose, the GBV-C/HGV 5' noncoding region (5'NCR) was amplified by reverse transcription-PCR and the amplified products were cloned and sequenced. These analyses showed that the master 5'NCR sequences isolated from the in vitro-infected PBMC and from the PBMC isolated from the patient whose serum was used as the inoculum were identical but different from that of the inoculum. Furthermore, phylogenetic analysis revealed that all PBMC sequences grouped together into a branch which was separate from those of the inoculum. For one of the two chronically infected patients, all the sequences from the PBMC and one from the liver clustered into a single branch while the sequences from the serum and all the other liver sequences grouped together in the other branch. For the other patient, the sequences from the serum and PBMC and three sequences from the liver grouped together into one branch, while the remaining five sequences from the liver were separated in a different cluster. In conclusion, our results support the existence of different GBV-C/HGV variants with different tissue tropism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933701      PMCID: PMC112324          DOI: 10.1128/jvi.74.17.7936-7942.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  GB virus-C RNA in Japanese patients with hepatocellular carcinoma and cirrhosis.

Authors:  T Kanda; O Yokosuka; F Imazeki; M Tagawa; T Ehata; H Saisho; M Omata
Journal:  J Hepatol       Date:  1997-09       Impact factor: 25.083

Review 2.  Clinical implications of GB virus C.

Authors:  I K Mushahwar; J N Zuckerman
Journal:  J Med Virol       Date:  1998-09       Impact factor: 2.327

3.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

Authors:  J D Thompson; T J Gibson; F Plewniak; F Jeanmougin; D G Higgins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

4.  GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C, and D.

Authors:  A Madejón; M Fogeda; J Bartolomé; M Pardo; C González; T Cotonat; V Carreńo
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

5.  Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells.

Authors:  J Mellor; G Haydon; C Blair; W Livingstone; P Simmonds
Journal:  J Gen Virol       Date:  1998-04       Impact factor: 3.891

6.  Lack of evidence for GB virus C/hepatitis G virus replication in peripheral blood mononuclear cells.

Authors:  M Radkowski; L F Wang; H Vargas; J Rakela; T Laskus
Journal:  J Hepatol       Date:  1998-02       Impact factor: 25.083

7.  Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients.

Authors:  S Navas; J Martín; J A Quiroga; I Castillo; V Carreño
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic.

Authors:  M G Pessoa; N A Terrault; J Detmer; J Kolberg; M Collins; H M Hassoba; T L Wright
Journal:  Hepatology       Date:  1998-03       Impact factor: 17.425

9.  Plus- and minus-stranded hepatitis G virus RNA in liver tissue and in peripheral blood mononuclear cells.

Authors:  S Saito; K Tanaka; M Kondo; K Morita; T Kitamura; T Kiba; K Numata; H Sekihara
Journal:  Biochem Biophys Res Commun       Date:  1997-08-18       Impact factor: 3.575

10.  Detection of hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR.

Authors:  T Laskus; M Radkowski; L F Wang; H Vargas; J Rakela
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

View more
  7 in total

Review 1.  Role of GB virus C in modulating HIV disease.

Authors:  Carolynne Schwarze-Zander; Jason T Blackard; Juergen K Rockstroh
Journal:  Expert Rev Anti Infect Ther       Date:  2012-05       Impact factor: 5.091

2.  Deep sequencing identifies two genotypes and high viral genetic diversity of human pegivirus (GB virus C) in rural Ugandan patients.

Authors:  Ria R Ghai; Samuel D Sibley; Michael Lauck; Jorge M Dinis; Adam L Bailey; Colin A Chapman; Patrick Omeja; Thomas C Friedrich; David H O'Connor; Tony L Goldberg
Journal:  J Gen Virol       Date:  2013-09-28       Impact factor: 3.891

Review 3.  Human Pegivirus Type 1: A Common Human Virus That Is Beneficial in Immune-Mediated Disease?

Authors:  Jack T Stapleton
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

4.  Hepatitis G virus genomic RNA is pathogenic to Macaca mulatta.

Authors:  Hao Ren; Fen-Lu Zhu; Ming-Mei Cao; Xin-Yu Wen; Ping Zhao; Zhong-Tian Qi
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

5.  Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro.

Authors:  Ernest T Chivero; Nirjal Bhattarai; Robert T Rydze; Mark A Winters; Mark Holodniy; Jack T Stapleton
Journal:  J Gen Virol       Date:  2014-03-25       Impact factor: 3.891

6.  Recombination among GB virus C (GBV-C) isolates in the United States.

Authors:  Jason T Blackard; Gang Ma; Clarissa Polen; Juwen C DuBois; Jonathon Gast; Caleb M Radens; Richard K Sterling; Kenneth E Sherman
Journal:  J Gen Virol       Date:  2016-04-11       Impact factor: 3.891

7.  Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication.

Authors:  Jinhua Xiang; James H McLinden; Qing Chang; Emma L Jordan; Jack T Stapleton
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.